R&D 100 Winner 2021: Antibody Therapeutic for SARS-CoV-2
Why the open web links it
Presents a novel antibody therapeutic for SARS-CoV-2 using nanobodies that are easier to manufacture and more effective.
Linked by 2 independent sites, 2 of them widely read in the 2026-10 crawl of the open web, including llnl.gov, sandia.gov.